Grifols
Contact information
- A. Health Biotechnology
- Areas of activity
- Biodrugs
- Stem cells
- In vitro diagnostics
- Cellular Therapy
- Gene Therapy
- Biomaterials and tissue therapy
- Vaccines
- Therapeutic areas
- Genetic and rare diseases
- Central nervous system
- C. Industrial Biotechnology
- Manufacture of biotech equipment
- D. Services
- R&D services
- Biotechnolgy kits
- Nanotechnology and in silico biology
- Professional services
- Consultancy
- Training and spreading
- Engineering
- Investment / Venture Capital
Grifols is a Spanish group of companies, specialized in the hospital pharmacy sector, with a presence in more than 100 different countries. Grifols is now the third plasma therapy producer in the world in terms of production capacity and the leading European company in this sector, due to a well-balanced diversified range of products.
Bioscience Division
It encompasses all activity relating to plasma derived therapies; this includes human plasma handling from its collection through the production process and the final marketing and distribution of these therapies as products.
Hospital Division
It covers non-biological pharmaceutical products, equipment, devices and healthcare supplies for hospital pharmacies such as parenteral solutions (fluid therapy), and enteral and parenteral clinical nutrition products.
Diagnostic Division
This division is specialized in in vitro diagnostics. It develops and manufactures equipment, instrumentation and reagents for transfusion medicine such as blood typing tests or donor-patient pre-transfusion compatibility tests. Its products are used by hospital blood banks, transfusion centers and clinical immunohematology laboratories. This division also markets instrumentation and reagents for immunology and hemostasis.